| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |